Clinical Features	Time to Death		AGE		KARNOFSKY.PERFORMANCE.SCORE		TUMOR.STAGE	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	t-test_P	t-test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q
TP53	276 (87%)	40	0.38919	1	0.64913	1	0.58484	1	0.74432	1
RB1	9 (3%)	307	0.24084	1	0.20377	1	NA	NA	1	1
BRCA1	12 (4%)	304	0.9574	1	0.6504	1	NA	NA	0.82745	1
CHST2	5 (2%)	311	0.85108	1	0.0727	1	NA	NA	0.023455	0.962
CSMD3	18 (6%)	298	0.26157	1	0.61024	1	0.28518	1	0.613	1
CYP11B1	7 (2%)	309	0.09265	1	0.79336	1	NA	NA	0.065287	1
FAT3	19 (6%)	297	0.13926	1	0.74339	1	0.64253	1	0.55195	1
GABRA6	6 (2%)	310	0.81537	1	0.012089	0.508	NA	NA	1	1
NF1	14 (4%)	302	0.20016	1	0.60568	1	NA	NA	0.62317	1
FAM171B	7 (2%)	309	0.61028	1	0.38838	1	NA	NA	1	1
GLI2	9 (3%)	307	0.1328	1	0.082918	1	NA	NA	0.47041	1
KCNJ12	5 (2%)	311	0.68805	1	0.64328	1	NA	NA	1	1
PPP1R3A	8 (3%)	308	0.53885	1	0.08191	1	NA	NA	0.16235	1